Search research articles
Contact Us
Filters
Showing results (1-10 of 35) with videos related to
Page
of 4
Sort By:
Stem Cells International
|
September 15, 2011
Optimization manufacture of virus- and tumor-specific T cells
Natalia Lapteva, Juan F Vera
Current Gene Therapy
|
October 29, 2009
Immunotherapy of human cancers using gene modified T lymphocytes
Juan F Vera, Malcolm K Brenner, Gianpietro Dotti
The Lancet. Oncology
|
October 2, 2013
Is cancer gene therapy an empty suit?
Malcolm K Brenner, Stephen Gottschalk, Ann M Leen, et al.
Journal of Visualized Experiments : Jove
|
June 10, 2011
Generation of multivirus-specific T cells to prevent/treat viral infections after allogeneic hematopoietic stem cell transplant
Ulrike Gerdemann, Juan F Vera, Cliona M Rooney, et al.
Cytotherapy
|
November 19, 2013
Engineered T cells for cancer treatment
Usanarat Anurathapan, Ann M Leen, Malcolm K Brenner, et al.
Immunological Reviews
|
December 17, 2013
T lymphocytes targeting native receptors
Cliona M Rooney, Ann M Leen, Juan F Vera, et al.
Haematologica
|
December 18, 2012
Robust and cost effective expansion of human regulatory T cells highly functional in a xenograft model of graft-versus-host disease
Rikhia Chakraborty, Aruna Mahendravada, Serena K Perna, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association
|
August 17, 2011
Engineered T cells for pancreatic cancer treatment
Usha L Katari, Jacqueline M Keirnan, Anna C Worth, et al.
Cytotherapy
|
December 17, 2011
Production of good manufacturing practice-grade cytotoxic T lymphocytes specific for Epstein-Barr virus, cytomegalovirus and adenovirus to prevent or treat viral infections post-allogeneic hematopoietic stem cell transplant
Uluhan Sili, Ann M Leen, Juan F Vera, et al.
Cancer Discovery
|
June 9, 2018
Enhancing the Potency and Specificity of Engineered T Cells for Cancer Treatment
Sujita Sukumaran, Norihiro Watanabe, Pradip Bajgain, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 35) with videos related to
Sort By:
Page
of 4
Stem Cells International
|
September 15, 2011
Optimization manufacture of virus- and tumor-specific T cells
Natalia Lapteva, Juan F Vera
Current Gene Therapy
|
October 29, 2009
Immunotherapy of human cancers using gene modified T lymphocytes
Juan F Vera, Malcolm K Brenner, Gianpietro Dotti
The Lancet. Oncology
|
October 2, 2013
Is cancer gene therapy an empty suit?
Malcolm K Brenner, Stephen Gottschalk, Ann M Leen, et al.
Journal of Visualized Experiments : Jove
|
June 10, 2011
Generation of multivirus-specific T cells to prevent/treat viral infections after allogeneic hematopoietic stem cell transplant
Ulrike Gerdemann, Juan F Vera, Cliona M Rooney, et al.
Cytotherapy
|
November 19, 2013
Engineered T cells for cancer treatment
Usanarat Anurathapan, Ann M Leen, Malcolm K Brenner, et al.
Immunological Reviews
|
December 17, 2013
T lymphocytes targeting native receptors
Cliona M Rooney, Ann M Leen, Juan F Vera, et al.
Haematologica
|
December 18, 2012
Robust and cost effective expansion of human regulatory T cells highly functional in a xenograft model of graft-versus-host disease
Rikhia Chakraborty, Aruna Mahendravada, Serena K Perna, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association
|
August 17, 2011
Engineered T cells for pancreatic cancer treatment
Usha L Katari, Jacqueline M Keirnan, Anna C Worth, et al.
Cytotherapy
|
December 17, 2011
Production of good manufacturing practice-grade cytotoxic T lymphocytes specific for Epstein-Barr virus, cytomegalovirus and adenovirus to prevent or treat viral infections post-allogeneic hematopoietic stem cell transplant
Uluhan Sili, Ann M Leen, Juan F Vera, et al.
Cancer Discovery
|
June 9, 2018
Enhancing the Potency and Specificity of Engineered T Cells for Cancer Treatment
Sujita Sukumaran, Norihiro Watanabe, Pradip Bajgain, et al.
Page
of 4